CNSX:ISOL

1mage Software Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume159,134 shs
Average Volume164,946 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive ISOL News and Ratings via Email

Sign-up to receive the latest news and ratings for 1mage Software and its competitors with MarketBeat's FREE daily newsletter.


1mage Software logo

About 1mage Software

Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; provision of apparel and merchandising solutions; manufactures and sells hemp infused beverages; and supplies pharmaceutical products. The company is headquartered in Vancouver, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











1mage Software (CNSX:ISOL) Frequently Asked Questions

What stocks does MarketBeat like better than 1mage Software?

Wall Street analysts have given 1mage Software a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but 1mage Software wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are 1mage Software's key executives?

1mage Software's management team includes the following people:
  • Mr. Marcos Agramont, CEO & Director
  • Mr. Patrick Edward Ogle J.D., L.L.M., COO & Director
  • Mr. Marvin Washington, VP & Director of Bus. Devel. and Director
  • Mr. Soheil Samimi, Advisor
  • Mr. Andrew S. Alvis, Pres, Interim CFO & Director
  • Mr. Kevin W. Swadish, Chief Revenue Officer

Who are some of 1mage Software's key competitors?

What other stocks do shareholders of 1mage Software own?

What is 1mage Software's stock symbol?

1mage Software trades on the CNSX under the ticker symbol "ISOL."

How do I buy shares of 1mage Software?

Shares of ISOL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How many employees does 1mage Software have?

1mage Software employs 15 workers across the globe.

What is 1mage Software's official website?

The official website for 1mage Software is www.1mage.com.

How can I contact 1mage Software?

The company can be reached via phone at 800-844-1468.


This page was last updated on 9/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.